A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...
Scientists designed and tested fluorescent molecules called “FibrilPaint” that bind exclusively to the long, thread-like ...
Alzheimer's disease is a progressive neurological disorder characterised by memory loss and cognitive decline, caused by ...
Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...
On Real Possibilities with AARP Michigan, associate professor of translational neuroscience Dr. Scott Counts from Michigan ...
Lewy Body Dementia (LBD) is a brain disease that’s often misunderstood. It’s actually the second most common type of ...
A new vitamin K-based treatment could help replenish lost neurons in Alzheimer's patients, offering hope for slowing ...
The 39-year-old from Hull lost his dad from Familial Alzheimer's disease (FAD) when he was a child and knew he had a 50:50 ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
Michael Borrie, physician and medical director of the Aging and Memory Clinic at St. Joseph’s Health Care London, said Health ...
A study published in 2023 found that using sleeping pills to get some shut-eye could reduce the buildup of toxic clumps of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback